Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-03-2019 | Montelukast | Rhinology

Effects of montelukast on human nasal mucosa

Authors: Hsing-Won Wang, Jih-Chin Lee, Pei-Chuan Wu, Yueng-Hsiang Chu, Yuan-Yung Lin, Li-Hsiang Cheng

Published in: European Archives of Oto-Rhino-Laryngology | Issue 3/2019

Abstract

Objective

Montelukast is a selective and orally active leukotriene D₄ receptor antagonist often used in treating asthma and allergic rhinitis. Montelukast nasal spray was developed to avoid systemic adverse effects of the drug in vitro. However, the effects of montelukast on human nasal mucosa are not yet fully explored and potential nasal vascular side effects of the drug merit further exploration. First, the effects of montelukast on vasocontractile responses generated by smooth muscles in the vascular structures of human nasal mucosa were investigated directly in vitro.

Methods

This study examined the effects of montelukast on human nasal mucosa in terms of mucosa resting tension, vasoconstriction caused by 10^− 6 M methoxamine as a sympathetic mimetic, and electrically induced vasoconstrictions.

Results

The results indicated that addition of methoxamine to the incubation medium caused the nasal mucosa to vasocontract in a dose-dependent manner. Addition of montelukast at doses of 10^− 5 M or above elicited a significant vasodilation response to 10^− 6 M methoxamine-induced vasoconstriction. Montelukast could not inhibit electrical field stimulation-induced spike vasoconstriction. Moreover, increase in concentration of montelukast had minimal effect on basal tension of nasal mucosa.

Conclusions

The study indicated significant vasodilation on human nasal mucosa under high concentrations of montelukast with a probable α-adrenoceptor antagonism. Hence, the nasal activity of α-adrenergic agonist nasal spray for nasal obstruction may be reduced in those using concomitant (oral or local spray) montelukast.

Cingi C, Muluk NB, Ipci K, Sahin E (2015) Antileukotrienes in upper airway inflammatory diseases. Curr Allergy Asthma Rep 15:64CrossRefPubMed

Jones TR, Labelle M, Belley M, Champion E, Charette L et al (1995) Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Phsiol Pharmacol 73:191–201CrossRef

Joachim RA, Quarcoo D, Arck PC, Herz U, Renz H et al (2003) Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom Med 65:811–815CrossRefPubMed

Perry TT, Corren J, Philip G, Kim EH, Conover-Walker MK et al (2004) Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure. Ann Allergy Asthma Immunol 93:431–438CrossRefPubMed

Papadopoulous NG, Philip G, Giezek H, Watkins M, Smugar SS et al (2009) The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity. J Asthma 46:413–420CrossRef

Philip G, Nayak AS, Berger WE (2004) The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 20:1549–1558CrossRefPubMed

Tuggey JM, Hosker HS (2000) Churg-Strauss syndrome associated with montelukast therapy. Thorax 55:805–806CrossRefPubMedPubMedCentral

Aypak C, Turedi O, Solmaz N, Yikilkan H, Gorpelioglu (2013) A rare adverse effect of montelukast treatment: ecchymosis. Respir Care 58:e104–e106CrossRefPubMed

Kocyigit A, Gulcan Oksuz B, Yarar F, Uzun F, Igde M et al (2013) Hallucination development with montelukast in a child with asthma: case presentation. Iran J Allergy Asthma Immunol 12:397–399PubMed

10.

Alkhuja S, Gazizov N, Alexander ME (2013) Sleeptalking! Sleepwalking! Side effects of montelukast. Case Rep Pulmonol 2013:813786

11.

Minciullo PL, Saija A, Bonanno D, Feriazzo E, Gangemi S (2004) Montelukast-induced generalized urticaria. Ann Pharmacother 38:999–1001CrossRefPubMed

12.

Jullaphant T, Nakpeng T, Srichana T (2018) Montelukast nasal spray: formulation development and in vitro evaluation. Pharm Dev Technol 27:1–10CrossRef

13.

Jackson RT (1979) A new in vitro method of drug assay of nasal blood vessels. Arch Otorhinolarygol 225:33–38CrossRef

14.

Jackson RT (1980) An in vitro technique for testing nasal vasodilating agent. Otolarygol Head Neck Surg 88:434–448CrossRef

15.

Wang HW, Jackson RT (1988) Effects of lidocaine and procaine on canine nasal blood vessels. Ann Oto Rhinol laryngol 97:409–413CrossRef

16.

Wang HW, Jackson RT (1988) Do cholinergic neurons directly innervate nasal blood vessels? Rhinology 26:139–146PubMed

17.

Wang HW, Wang SW, Wang JY, Su. WY (1996) Effects of amphetamine on human nasal mucosa. Eur Arch Otorhinolaryngol 253:498–500PubMed

18.

Fayyaz A, Khan JA, Ashraf MM et al (2017) Pharmacokinetic behavior of montelukast in indigenous healthy male volunteers. Park J Pharm Sci 30(6 suppl):2435–2439

19.

Cobb DB, Abbott CL, Waston WA, Fernandez MC (2002) High-dose montelukast exposures in a 3-year-old and 5-year-old. Vet Hum Toxicol 44:91–92PubMed

20.

Geller M, Melo LR, Coutinho SV (2000) Successful outcome of montelukast overdosage in an asthmatic child. Ann Allergy Asthma Immunol Mar 84:370CrossRef

21.

Donald H, Arnold N, Bowan TF, Seger DL (2018) Adverse events are rare after single-dose montelukast exposures in children. Clin Toxicol 56:25–29CrossRef

22.

Kao CH, Chu YH, Wang HW (2008) Effects of oxymetazoline on isolated rat’s tracheal smooth muscle. Eur Arch Otorhinolaryngol 265:695–698CrossRef

Title: Effects of montelukast on human nasal mucosa
Authors: Hsing-Won Wang
Jih-Chin Lee
Pei-Chuan Wu
Yueng-Hsiang Chu
Yuan-Yung Lin
Li-Hsiang Cheng
Publication date: 01-03-2019
Publisher: Springer Berlin Heidelberg
Keyword: Montelukast
Published in: European Archives of Oto-Rhino-Laryngology / Issue 3/2019
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-018-05274-8

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Effects of montelukast on human nasal mucosa

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2019

Ectoine lozenges in the treatment of acute viral pharyngitis: a prospective, active-controlled clinical study

Efficacy of allergen-blocker mechanical barrier gel on symptoms and quality of life in patients with allergic rhinitis

Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study

Colour Doppler sonography in the preoperative assessment of the vascular pedicle from the anterolateral thigh flap: proposal for a mathematical formula to predict pedicle length

Microcirculation evaluation of facial nerve palsy using laser speckle contrast imaging: a prospective study

Performance metrics in mastoidectomy training: a systematic review